STOCK TITAN

Rocket Lab (NASDAQ: RKLB) director awarded 2,482 RSUs in equity grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Frank Edward H. reported acquisition or exercise transactions in this Form 4 filing.

Rocket Lab Corp director Frank Edward H. received an equity grant of 2,482 restricted stock units (RSUs). These RSUs were awarded under Rocket Lab’s Amended and Restated Non-Employee Director Compensation Policy and its 2021 Stock Option and Incentive Plan as part of his board compensation.

The RSUs will vest in full on the earlier of the company’s next Annual Meeting of Stockholders or the one-year anniversary of the grant date, as long as he continues serving on the board through that date. Following this grant, he holds 144,986 shares of Rocket Lab common stock directly.

Positive

  • None.

Negative

  • None.
Insider Frank Edward H.
Role null
Type Security Shares Price Value
Grant/Award Common Stock 2,482 $0.00 --
Holdings After Transaction: Common Stock — 144,986 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSUs granted 2,482 units Restricted stock units granted to director as of May 20, 2026
Grant price $0.00 per unit Equity award under director compensation plans
Shares after grant 144,986 shares Total Rocket Lab common stock held directly after transaction
restricted stock units ("RSUs") financial
"Represents restricted stock units ("RSUs") granted to the Reporting Person"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Amended and Restated Non-Employee Director Compensation Policy financial
"granted to the Reporting Person under the Rocket Lab Corporation Amended and Restated Non-Employee Director Compensation Policy"
2021 Stock Option and Incentive Plan financial
"and the Rocket Lab Corporation 2021 Stock Option and Incentive Plan"
Annual Meeting of Stockholders financial
"will vest in full on the earlier of (i) the date of the Registrant's next Annual Meeting of Stockholders"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Frank Edward H.

(Last)(First)(Middle)
3881 MCGOWEN STREET

(Street)
LONG BEACH CALIFORNIA 90808

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Rocket Lab Corp [ RKLB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/20/2026A2,482(1)A$0.0144,986D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units ("RSUs") granted to the Reporting Person under the Rocket Lab Corporation Amended and Restated Non-Employee Director Compensation Policy, and the Rocket Lab Corporation 2021 Stock Option and Incentive Plan. Such RSUs will vest in full on the earlier of (i) the date of the Registrant's next Annual Meeting of Stockholders and (ii) the one-year anniversary of the date of grant, subject to the Reporting Person's continuous service as a member of the Board of Directors through such date.
By: /s/ Arjun Kampani as Attorney-in-Fact For: Edward H. Frank05/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Rocket Lab (RKLB) report for director Frank Edward H.?

Rocket Lab reported that director Frank Edward H. received a grant of 2,482 restricted stock units (RSUs) as part of his non-employee director compensation. These units represent stock-based compensation rather than an open-market share purchase or sale.

How many Rocket Lab (RKLB) shares does Frank Edward H. hold after this Form 4 transaction?

After this grant, Frank Edward H. holds 144,986 shares of Rocket Lab common stock directly, according to the Form 4. This total includes the newly granted 2,482 restricted stock units, which are subject to vesting conditions tied to his continued board service.

What are the vesting terms of the RSUs granted to Rocket Lab (RKLB) director Frank Edward H.?

The 2,482 RSUs will vest in full on the earlier of Rocket Lab’s next Annual Meeting of Stockholders or the one-year anniversary of the grant date. Vesting is contingent on Frank Edward H. continuing to serve on the board through the applicable vesting date.

Under which plans were the RSUs to Rocket Lab (RKLB) director granted?

The RSUs were granted under Rocket Lab Corporation’s Amended and Restated Non-Employee Director Compensation Policy and the Rocket Lab Corporation 2021 Stock Option and Incentive Plan. These programs govern stock-based compensation for non-employee directors of the company.

Did Rocket Lab (RKLB) director Frank Edward H. buy or sell shares in this Form 4?

The Form 4 shows an acquisition through a grant of 2,482 restricted stock units at a price of $0.00 per unit. This reflects stock-based compensation, not an open-market purchase or sale initiated by the director.